Introduction and first vote
| Date | 29 September 2014 |
| Event | ESMO 2014 |
| Session | Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT) |
| Topics | Cytotoxic agents Prostate Cancer Therapy Biological therapy |
| Presenter | Eleni Efstathiou |
| Authors |
E. Efstathiou
|